Bide Pharmatech Co. Ltd. A Cash Flow Reinvestment Rate
Bide Pharmatech Co. Ltd. A cash flow reinvestment rate. Bide Pharmatech Co. Ltd. A (688073) has a Cash Flow Reinvestment Rate of 2.48x as of December 2025, reinvesting CN¥70.18 Million (capex CN¥24.28 Million plus investments CN¥-45.90 Million) from operating cash flow of CN¥28.32 Million. See Bide Pharmatech Co. Ltd. A leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Bide Pharmatech Co. Ltd. A (2020–2025)
Cash flow reinvestment rate of Bide Pharmatech Co. Ltd. A from 2020 to 2025. Historical reinvestment intensity for Bide Pharmatech Co. Ltd. A across 4 annual periods. Explore 688073 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Bide Pharmatech Co. Ltd. A Cash Flow Reinvestment Rate by Year (2020–2025)
Bide Pharmatech Co. Ltd. A cash flow reinvestment rate by year from 2020 to 2025. Year-by-year capital reinvestment analysis for Bide Pharmatech Co. Ltd. A. For the full cash flow conversion analysis, see 688073 cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.48x | CN¥70.18 Million | CN¥28.32 Million | CN¥24.28 Million | ▲ +143.0% |
| 2024 | 1.02x | CN¥161.42 Million | CN¥158.31 Million | CN¥88.35 Million | ▼ -62.4% |
| 2022 | 2.71x | CN¥81.02 Million | CN¥29.87 Million | CN¥38.41 Million | ▼ -91.6% |
| 2020 | 32.28x | CN¥117.65 Million | CN¥3.65 Million | CN¥37.73 Million | — |